Riken Vitamin Co., Ltd.

As of March 31, 2026, Riken Vitamin Co., Ltd. carries a market capitalization of 83.83B, placing it among publicly traded companies globally. Its enterprise value stands at 70.94B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Riken Vitamin Co., Ltd.'s next confirmed earnings release is scheduled for November 12, 2026.

As of March 31, 2026, Riken Vitamin Co., Ltd. has 29.19M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Riken Vitamin Co., Ltd. maintains a current ratio of 3.41, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Riken Vitamin Co., Ltd.'s stock has gained approximately 13.35% over the past 52 weeks. The 50-day moving average sits at 3,257.20, while the 200-day moving average is 3,054.07.

As of March 31, 2026, Riken Vitamin Co., Ltd. holds 20.07B in cash and equivalents against 7.14B in total debt, resulting in a net debt position of -12.93B. Total book value stands at 83.34B, with working capital of 46.79B providing operational flexibility.

Riken Vitamin Co., Ltd.'s most recent stock split took place on March 30, 2020 with a 1:2 split ratio.